Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
1,187 stocks in the Americas match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| EYPT | EyePoint, Inc. | Healthcare | $430.20M | $4.99 | −73.89% | −58.28% |
| FRX.TO | Fennec Pharmaceuticals Inc. | Healthcare | $429.52M | 17.00 CAD | −3.63% | +21.86% |
| MASS | 908 Devices Inc. | Healthcare | $428.63M | $10.37 | −7.81% | +47.51% |
| CCRN | Cross Country Healthcare Inc | Healthcare | $428.06M | $13.25 | −11.61% | 0.00% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| FENC | Fennec Pharmaceuticals Inc. | Healthcare | $426.77M | $12.17 | −8.15% | +22.43% |
| LXEO | Lexeo Therapeutics, Inc. | Healthcare | $420.90M | $5.01 | −54.41% | +14.12% |
| GALT | Galectin Therapeutics Inc. | Healthcare | $418.53M | $4.15 | −41.80% | +22.42% |
| XFOR | X4 Pharmaceuticals, Inc. | Healthcare | $412.45M | $4.17 | −13.66% | +6.11% |
| ENTA | Enanta Pharmaceuticals, Inc. | Healthcare | $412.12M | $14.15 | −17.49% | +12.21% |
| BLAU3.SA | Blau Farmacêutica S.A. | Healthcare | $406.91M | 9.07 BRL | −37.45% | +4.13% |
| RCKT | Rocket Pharmaceuticals, Inc. | Healthcare | $401.78M | $3.66 | −32.84% | +16.56% |
| FHTX | Foghorn Therapeutics Inc. | Healthcare | $397.29M | $6.69 | −12.09% | +30.41% |
| OFIX | Orthofix Medical Inc. | Healthcare | $397.14M | $9.75 | −42.61% | −20.47% |
| TBRG | TruBridge Inc | Healthcare | $393.58M | $26.24 | −1.02% | 0.00% |
| IPSC | Century Therapeutics, Inc. | Healthcare | $392.93M | $2.14 | −29.61% | +4.39% |
| UPB | Upstream Bio, Inc. | Healthcare | $390.52M | $7.13 | −78.83% | +11.41% |
| TKNO | Alpha Teknova, Inc. | Healthcare | $387.63M | $7.22 | −7.91% | +41.85% |
| E2NO34.SA | Enovis Corporation | Healthcare | $387.44M | 34.59 BRL | −20.00% | +7.86% |
| MOBI | Mobia Medical, Inc. | Healthcare | $387.35M | $11.65 | −23.81% | +8.68% |
| AUNA | Auna SA | Healthcare | $387.31M | $5.23 | −23.65% | +0.58% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | Healthcare | $381.80M | 1.92 BRL | −50.86% | +214.75% |
| SLP | Simulations Plus, Inc. | Healthcare | $372.34M | $18.41 | −12.38% | +0.44% |
| AGEN | Agenus Inc. | Healthcare | $371.33M | $8.25 | −6.78% | +25.00% |
| PALI | Palisade Bio, Inc. | Healthcare | $371.20M | $2.13 | −25.52% | +5.45% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | Healthcare | $368.27M | $3.89 | −44.03% | −15.80% |
| VHI.TO | Vitalhub Corp. | Healthcare | $364.45M | 8.11 CAD | −41.27% | +16.69% |
| LYEL | Lyell Immunopharma, Inc. | Healthcare | $362.68M | $15.49 | −65.58% | +19.25% |
| DMAC | DiaMedica Therapeutics Inc. | Healthcare | $361.30M | $6.70 | −35.70% | +0.90% |
| CATX | Perspective Therapeutics, Inc. | Healthcare | $360.72M | $3.16 | −48.70% | +10.10% |
| IFRX | InflaRx N.V. | Healthcare | $356.63M | $2.42 | −17.94% | +43.20% |
| STRO | Sutro Biopharma, Inc. | Healthcare | $355.50M | $21.43 | −51.13% | −9.69% |
| VMD | Viemed Healthcare, Inc. | Healthcare | $355.36M | $9.33 | −26.01% | −21.73% |
| SABS | SAB Biotherapeutics, Inc. | Healthcare | $353.03M | $3.88 | −24.66% | +12.46% |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | Healthcare | $350.76M | 12.09 BRL | −27.04% | +4.22% |
| IKT | Inhibikase Therapeutics, Inc. | Healthcare | $347.44M | $2.49 | −1.97% | +7.79% |
| CLLS | Cellectis S.A. | Healthcare | $344.40M | $3.42 | −37.59% | +20.42% |
| ABEO | Abeona Therapeutics Inc. | Healthcare | $343.68M | $6.01 | −21.44% | −0.17% |
| NNNN | Anbio Biotechnology | Healthcare | $343.67M | $7.72 | −85.42% | −23.94% |
| IMRX | Immuneering Corporation | Healthcare | $333.19M | $5.15 | −48.91% | +21.46% |
| P2OD34.SA | Insulet Corporation | Healthcare | $332.45M | 24.68 BRL | −26.24% | −12.58% |
| PRQR | ProQR Therapeutics N.V. | Healthcare | $331.63M | $2.35 | −24.19% | +33.52% |
| RCEL | AVITA Medical, Inc. | Healthcare | $327.52M | $10.59 | −1.67% | +129.72% |
| VNDA | Vanda Pharmaceuticals Inc. | Healthcare | $323.48M | $5.35 | −46.18% | +3.68% |
| MATD3.SA | Hospital Mater Dei S.A. | Healthcare | $321.33M | 5.01 BRL | −18.80% | +1.62% |
| SMTI | Sanara MedTech Inc. | Healthcare | $318.55M | $34.65 | −3.62% | +30.07% |
| OBIO | Orchestra BioMed Holdings, Inc. | Healthcare | $316.15M | $5.26 | −9.00% | +36.27% |
| IRD | Opus Genetics, Inc. | Healthcare | $316.14M | $3.80 | −34.60% | +11.44% |
| RNAC | Cartesian Therapeutics, Inc. | Healthcare | $308.30M | $10.19 | −13.64% | +33.20% |
| YDES | YD Bio Ltd | Healthcare | $307.41M | $4.34 | −82.64% | +88.70% |
| TMCI | Treace Medical Concepts, Inc. | Healthcare | $306.96M | $4.72 | −39.33% | +17.71% |
| EBS | Emergent BioSolutions Inc. | Healthcare | $306.10M | $5.97 | −57.54% | −18.33% |
| FATE | Fate Therapeutics, Inc. Common Stock | Healthcare | $305.54M | $2.57 | −20.43% | +10.78% |
| BCYC | Bicycle Therapeutics plc | Healthcare | $304.03M | $4.36 | −52.45% | +10.53% |
| TLSI | TriSalus Life Sciences, Inc. | Healthcare | $303.56M | $4.93 | −37.99% | +13.86% |
| AMRN | Amarin Corporation plc | Healthcare | $301.43M | $14.38 | −31.22% | +3.05% |
| AVXL | Anavex Life Sciences Corp. | Healthcare | $300.34M | $3.24 | −68.85% | +26.07% |
| MYGN | Myriad Genetics, Inc. | Healthcare | $298.43M | $3.12 | −63.68% | −41.35% |
| TRDA | Entrada Therapeutics, Inc. | Healthcare | $296.70M | $7.00 | −57.45% | +20.07% |
| BDSX | Biodesix, Inc. | Healthcare | $296.22M | $30.60 | −2.27% | +45.51% |
| FULC | Fulcrum Therapeutics, Inc. | Healthcare | $294.51M | $3.86 | −75.48% | +3.76% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.